Table 2.
Regulators | HRa | 95% CI |
p-valueb | |
---|---|---|---|---|
Low | High | |||
Writers | ||||
KIAA1429 | 1.01 | 0.932 | 1.095 | 0.808 |
RBM15 | 0.839 | 0.738 | 0.954 | 0.008 |
METTL14 | 0.811 | 0.623 | 1.058 | 0.122 |
METTL3 | 0.928 | 0.813 | 1.059 | 0.269 |
ZC3H13 | 0.996 | 0.969 | 1.025 | 0.799 |
WTAP | 0.949 | 0.886 | 1.017 | 0.139 |
Readers | ||||
YTHDC1 | 0.942 | 0.858 | 1.034 | 0.208 |
YTHDC2 | 1.016 | 0.889 | 1.162 | 0.812 |
YTHDF1 | 0.996 | 0.978 | 1.014 | 0.627 |
YTHDF2 | 0.961 | 0.922 | 1.001 | 0.055 |
YTHDF3 | 0.994 | 0.961 | 1.028 | 0.727 |
HNRNPC | 0.994 | 0.976 | 1.012 | 0.511 |
HNRNPA2B1 | 0.993 | 0.986 | 1.001 | 0.069 |
Erasers | ||||
FTO | 1.116 | 0.976 | 1.276 | 0.108 |
ALKBH5 | 0.97 | 0.943 | 0.999 | 0.045 |
m6A, N6-methyladenosine; STAD, stomach adenocarcinoma; HR, hazard ratio; CI, confidence interval.
aValues >1.0 indicate that expression is positively associated with poor survival.
bLikelihood ratio test p-value; significant values < 0.05.